Description

LuciVenet 100mg Tablet (Venetoclax) – Uses, Side Effects, Dosage & Price in Pakistan

LuciVenet 100mg Tablet (Venetoclax) is an oral prescription anticancer medicine containing venetoclax. It belongs to a class of targeted cancer medicines known as BCL-2 inhibitors and is used for certain blood cancers, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and selected patients with acute myeloid leukemia (AML).

Venetoclax works differently from traditional chemotherapy. It targets the BCL-2 protein, which helps certain cancer cells survive. By blocking this protein, venetoclax can promote the death of susceptible cancer cells.

LuciVenet 100mg Tablet requires strict specialist supervision because treatment can cause tumor lysis syndrome (TLS), a potentially life-threatening complication that may occur when cancer cells break down rapidly. Blood tests, hydration, preventive medicines, and a carefully planned dose-escalation schedule may therefore be required.

Patients looking for LuciVenet 100mg Tablet in Pakistan can check product information and availability through Impo Medic. Venetoclax must never be started or dose-adjusted without an oncologist or hematologist.

LuciVenet 100mg Tablet (Venetoclax) Uses

Venetoclax is primarily used for selected hematological cancers. The treatment regimen varies significantly according to the disease being treated.

Chronic Lymphocytic Leukemia (CLL)

Venetoclax is approved for the treatment of adults with chronic lymphocytic leukemia.

CLL is a blood cancer involving abnormal lymphocytes. Venetoclax may be used as part of different treatment strategies depending on previous treatment and the patient’s clinical circumstances.

Small Lymphocytic Lymphoma (SLL)

LuciVenet 100mg Tablet (Venetoclax) may also be used for adults with small lymphocytic lymphoma.

CLL and SLL involve similar abnormal lymphocytes but differ mainly in where the disease is predominantly found.

The hematologist determines the most appropriate venetoclax-containing regimen for each patient.

Acute Myeloid Leukemia (AML)

Venetoclax is also used in combination with certain other medicines for newly diagnosed acute myeloid leukemia in adults who are 75 years or older or have medical conditions that make intensive induction chemotherapy unsuitable.

In this setting, venetoclax may be combined with:

• Azacitidine
• Decitabine
• Low-dose cytarabine

AML dosing and ramp-up schedules differ from those used for CLL/SLL, so patients must follow their specialist’s exact treatment plan.

How Does LuciVenet 100mg Tablet Work?

Venetoclax is a selective inhibitor of B-cell lymphoma-2 (BCL-2) protein.

BCL-2 is an anti-apoptotic protein, meaning it can help cells avoid the normal process of programmed cell death. Some blood cancer cells depend heavily on BCL-2 for survival.

Venetoclax binds to and inhibits BCL-2. This can restore the process of programmed cell death in susceptible cancer cells and help reduce the number of malignant cells.

Because this effect can occur rapidly, treatment may cause a sudden breakdown of many cancer cells. This explains why tumor lysis syndrome prevention and monitoring are particularly important when starting treatment or increasing the dose.

LuciVenet 100mg Tablet Dosage

The dose of LuciVenet 100mg Tablet depends on the cancer being treated, treatment phase, combination medicines, drug interactions, and individual patient factors.

CLL and SLL Dose Ramp-Up

For CLL/SLL, venetoclax treatment generally begins with a 5-week dose ramp-up:

Week 1: 20mg once daily
Week 2: 50mg once daily
Week 3: 100mg once daily
Week 4: 200mg once daily
Week 5 and beyond: 400mg once daily according to the prescribed treatment regimen.

This gradual increase is specifically designed to reduce the risk of tumor lysis syndrome.

Therefore, a LuciVenet 100mg Tablet does not mean that 100mg is automatically the patient’s regular daily dose.

AML Dosing

For AML, venetoclax uses a different and shorter ramp-up schedule, and the eventual dose depends partly on the other medicine used in combination.

The treating hematologist or oncologist must determine the correct AML regimen.

Never copy a CLL/SLL venetoclax schedule for an AML patient or vice versa.

How to Take LuciVenet 100mg Tablet

Venetoclax should generally be taken once daily with a meal and water.

Take the medicine at approximately the same time each day according to your prescribed treatment schedule.

Tablets should be swallowed whole. Do not chew, crush, or break them before swallowing.

Adequate hydration is particularly important when starting venetoclax and during dose escalation because it forms part of the strategy used to reduce TLS risk.

If a dose is missed or vomiting occurs after a dose, follow the instructions provided by your treatment team rather than taking an additional tablet without advice.

Tumor Lysis Syndrome – Important Warning

Tumor lysis syndrome (TLS) is one of the most important risks associated with LuciVenet 100mg Tablet (Venetoclax).

TLS occurs when large numbers of cancer cells break down rapidly and release their contents into the bloodstream. This can cause dangerous changes in potassium, uric acid, phosphorus, calcium, and kidney function.

Severe TLS can result in:

• Kidney failure
• Abnormal heart rhythm
• Seizures
• Serious metabolic abnormalities
• Death in severe cases

Before treatment, doctors assess factors such as tumor burden and kidney function. Patients may require blood tests, adequate hydration, medicines to control uric acid, and frequent laboratory monitoring.

Some higher-risk patients may require more intensive monitoring or hospitalization when treatment begins or the dose is increased.

Never skip the prescribed blood tests during venetoclax ramp-up.

Common Side Effects of LuciVenet 100mg Tablet

Side effects can vary according to the cancer being treated and other medicines used with venetoclax.

Possible adverse effects include:

• Low white blood-cell counts
• Low red blood-cell counts
• Low platelet counts
• Diarrhea
• Nausea
• Tiredness
• Constipation
• Reduced appetite
• Infections
• Fever
• Vomiting

Blood-cell abnormalities are particularly important because they can increase the risk of infection, bleeding, or anemia.

Regular complete blood counts may therefore be required throughout treatment.

Neutropenia and Risk of Infection

Venetoclax can cause neutropenia, which means a reduction in neutrophils, an important type of white blood cell.

Severe neutropenia can make patients more vulnerable to infection.

Contact your healthcare team promptly if you develop:

• Fever
• Chills
• Persistent cough
• Shortness of breath
• Painful urination
• Other signs of infection

Your specialist may interrupt treatment, reduce the dose, or provide supportive treatment depending on the severity of the problem.

Drug Interactions

Drug interactions are especially important with venetoclax because some medicines can substantially increase its concentration in the body.

Strong or moderate CYP3A inhibitors and P-glycoprotein inhibitors can increase venetoclax exposure and consequently increase toxicity and TLS risk.

For patients with CLL/SLL, using a strong CYP3A inhibitor during treatment initiation and the ramp-up phase is contraindicated.

Other interacting medicines may require venetoclax dose adjustments.

Tell your specialist about every medicine you take, including:

• Prescription medicines
• Antibiotics
• Antifungal medicines
• Non-prescription products
• Vitamins
• Herbal supplements

Do not start or stop another medicine without informing your oncology or hematology team.

Food and Drink Precautions

Take venetoclax with a meal and water according to your prescription.

Certain foods can influence CYP3A activity and may affect venetoclax exposure. Follow the food restrictions given in the product information and by your healthcare team.

Do not assume that herbal or natural products are safe to combine with cancer medicines. Discuss all supplements with your specialist.

Vaccinations During Venetoclax Treatment

Discuss vaccinations with your healthcare team before receiving them.

Because venetoclax treatment can affect immune function, live vaccines should generally be avoided before, during, and after treatment until immune recovery, according to specialist advice.

Do not receive a vaccine during cancer treatment without informing the healthcare professional administering it about your medicines.

Pregnancy and Breastfeeding

Venetoclax can cause harm to an unborn baby.

Women who can become pregnant should discuss effective contraception with their healthcare professional and follow the recommended contraception period during treatment and after the final dose.

Tell your doctor immediately if pregnancy occurs during treatment.

Breastfeeding is not recommended during venetoclax therapy and for the period specified after the final dose.

Patients with concerns about fertility, pregnancy, or breastfeeding should discuss them with their oncology team before treatment.

Liver and Kidney Considerations

Kidney function is particularly important because reduced renal function can increase the risk of tumor lysis syndrome.

Patients with kidney problems may therefore require more intensive TLS prevention and monitoring.

Severe liver impairment can also affect venetoclax dosing. Current prescribing information recommends dose reduction in patients with severe hepatic impairment.

Patients should make sure their specialist knows their complete medical history before treatment begins.

Storage of LuciVenet 100mg Tablet

Store LuciVenet 100mg Tablet according to the conditions printed on the original packaging.

Keep tablets in their original container or packaging and protect them from excessive moisture and inappropriate temperatures.

Keep all anticancer medicines securely out of the reach of children.

Do not use expired tablets or medicine from damaged packaging.

Because LuciVenet is a brand-specific product, follow the storage instructions printed on the actual pack.

LuciVenet 100mg Tablet Price in Pakistan

The LuciVenet 100mg Tablet price in Pakistan can vary according to pack size, availability, supplier, import costs, and market conditions.

Patients should confirm the current price rather than relying on an old online listing because oncology medicine prices can change.

Customers can check the latest LuciVenet 100mg Tablet price and availability in Pakistan through Impo Medic.

When purchasing an anticancer medicine, consider product authenticity, correct strength, batch information, expiry date, packaging condition, and appropriate storage alongside price.

How to Buy LuciVenet 100mg Tablet in Pakistan

Patients looking to buy LuciVenet 100mg Tablet in Pakistan should have a valid prescription and treatment plan from an oncologist or hematologist.

Customers can contact Impo Medic to check LuciVenet 100mg Tablet availability and purchasing information in Pakistan.

Before purchasing, verify:

• Correct product name
• Venetoclax as the active ingredient
• 100mg tablet strength
• Prescribed quantity
• Original packaging
• Batch and expiry details
• Appropriate storage conditions

Never purchase venetoclax for self-treatment or use another patient’s dosing schedule.

Why Choose Impo Medic?

Impo Medic provides medicine-related product information for patients and caregivers searching for specialist and oncology medicines in Pakistan.

For a medicine such as LuciVenet, accurate strength and treatment instructions are particularly important because venetoclax uses different dose-escalation schedules depending on the disease and treatment regimen.

Impo Medic can help customers check product availability and purchasing information, while all decisions about starting treatment, ramp-up, combination therapy, dose adjustment, and monitoring must remain with the treating oncology or hematology specialist.

FAQs About LuciVenet 100mg Tablet (Venetoclax)

What is LuciVenet 100mg Tablet used for?

Venetoclax is used for adults with CLL or SLL and, in combination with specific medicines, for certain adults with newly diagnosed AML who meet appropriate treatment criteria.

Does LuciVenet 100mg contain venetoclax?

LuciVenet 100mg Tablet is described as containing venetoclax. Patients should verify the active ingredient and strength on the actual product packaging.

Is LuciVenet chemotherapy?

Venetoclax is a targeted BCL-2 inhibitor, rather than conventional cytotoxic chemotherapy. However, it is a powerful anticancer medicine and requires specialist monitoring.

Is LuciVenet 100mg taken every day from the start?

Not necessarily. In CLL/SLL, venetoclax treatment begins with a carefully controlled 5-week ramp-up starting at a lower dose. The 100mg strength appears during this escalation but should not automatically be used as the starting dose.

Why is venetoclax dose increased slowly?

Gradual dose escalation helps reduce the risk of tumor lysis syndrome, which can occur when cancer cells are destroyed rapidly.

Should venetoclax be taken with food?

Yes. Venetoclax tablets are generally taken once daily with a meal and water according to the prescribed schedule.

Can LuciVenet lower white blood cells?

Yes. Neutropenia is an important adverse effect of venetoclax. Regular blood-count monitoring may be necessary.

Where can I check LuciVenet 100mg price in Pakistan?

Patients can check current LuciVenet 100mg Tablet price and availability in Pakistan through Impo Medic. Confirm current stock and price at the time of purchase.